You are on page 1of 1

CLINIPATH MALAYSIA SDN BHD (248187-W) Req No : 101113114

No.23, Galeri Empire


Jalan Empayar Off Persiaran
Sultan Ibrahim/KU1 MUHAMMAD RIFAIE DR SHARIF BIN OTHMAN
41150 Klang Bandar Diraja PUTRA SPECIALIST HOSP (PROJECT)
Selangor Darul Ehsan (BATU PAHAT) SDN. BHD.
1, JALAN PESERAI
Tel: (03) 3342 2828 (H.Line)
BATU PAHAT, JOHOR 83000
Fax: (03) 3343 5858 PHONE : 07-4133333
Sex : Male Age : 50
Email: enquiries@clinipath.com.my
Website: www.clinipath.com.my
I/C : C3486874
Service Date: 17/05/2020
RESULTS: TEL (03) 3342 2828

SARS-CORONAVIRUS-2 PCR ASSAY (Novel Coronavirus / COVID-19)

Nature of Specimen Nasopharyngeal / Oropharyngeal Swab

Screening Assay for SARS-CoV-2 Not Detected

Method:
Multiplex Real Time Reverse Transcriptase PCR (RT-PCR) which simultaneously detects several
Coronavirus specific genes such as E, N, S, RdRp, ORF1ab.

This RT-PCR assay is specific and sensitive having a limit of detection ranging from 3.8 copys /
reaction (RdRp), 10 copys / reaction (ORF1ab, N, S) and 5.2 copys / reaction for E gene.

A "Detected" result strongly indicates probable infection and should be read in conjunction with
clinical symptoms, exposure, travel and epidemiological history.

A "Not Detected" result indicates that no SARS-2 Coronavirus genes is present in sample / swab.
This may also occur in very early or late infection. If there is a strong suspicion of COVID-19 disease,
then it is advised to repeat sampling (NPS and OPS) for retesting.

It is also recommended to test for other respiratory viruses in the Respiratory Panel 33 PCR in severely
ill patients to exclude or confirm the role of other co-infecting pathogens.

Ref: Guidelines COVID-19 Management in Malaysia No: 05/2020 (Edisi Kelima) Dated 25 March 2020

Note: Please refer to Clinipath website for the test methods Final Report
Test(s) Requested : NCOV2
Service Date : 17/05/2020 Report Date : 21/05/2020 Report Time: 21:08 Validated by : Ezamizudin Bsc.(Hons)Biomed.Sc.,UPM Page 1 of 1

You might also like